Skip to content

Clinical trials

Completed Observational Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Observational Status: Completed Clear all

196 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20033
20041
20054
20068
20076
200816
200910
201011
20114
201216
201312
20148
201516
20165
20179
20188
201911
202014
20218
20229
20237
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed196

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)20
Notal Vision Ltd.19
Bayer15
Novartis Pharmaceuticals10
Association for Innovation and Biomedical Research on Light and Image7
Duke University5
Pfizer4
Sequenom, Inc.4
Fondation Ophtalmologique Adolphe de Rothschild3
Oregon Health and Science University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration196
Diabetic Retinopathy23
Choroidal Neovascularization16
Glaucoma12
Retinal Vein Occlusion12
Geographic Atrophy10
Macular Edema8
Cataract7
Retinal Diseases7
Diabetes Mellitus5

Trials

Showing 1 to 25 of 196. Each trial links to its page on Pharma Observatory.

96 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.